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Abstract
Background: Prosthetic hip implants have many combinations of bearing surface materials, sizes, and fixation
techniques, which can determine the quality of life of patients after primary total hip replacement (THR) and the
likelihood of needing revision surgery. When an implant fails, patients require revision THR, which is distressing to
the patient and expensive for the health care payer. Primary THR is one of the most common elective procedures
performed worldwide, with over 300,000 performed annually in the USA and over 80,000 in England and Wales. It is
important to review all available randomised controlled trial (RCT) evidence to determine which implant bearing
surface materials, size, and fixation technique are most effective for patients.
Methods/Design: This is a protocol for a systematic review and meta-analysis of RCTs comparing outcomes of hip
implant bearing surfaces, size, and fixation techniques used in THR. Implant combinations compared in the literature
include four bearing surface combinations (metal-on-polyethylene, metal-on-metal, ceramic-on-polyethylene, and
ceramic-on-ceramic); two femoral head sizes (large vs small heads); and four fixation techniques (uncemented,
cemented, hybrid, and reverse hybrids). The primary outcome will be revision surgery. We will also collect data on
patient characteristics, mortality, quality of life, and other outcomes. In network meta-analysis, we will estimate the
relative effectiveness of every implant bearing surface, head size (large vs small), and fixation permutation, using
evidence where implants have been compared directly in an RCT and indirectly through common comparators in
different RCTs.
Discussion: There has been much debate about materials used for prosthetic implants in THR. Different combinations
of prosthetic materials, sizes, and fixation, can vary widely in cost and fail at different rates for different patient groups.
Given the number of THRs performed yearly, and the increasing use of expensive implants, it is important to review
evidence to inform surgeons, patients, and health care providers of optimal implant bearing combinations for given
patient characteristics. This review will inform a cost-effectiveness model that will include evidence from other sources,
to determine the most effective and cost-effective implant bearing combination for patients.
Systematic review registration: PROSPERO CRD42015019435
Keywords: Hip prosthesis, Hip implant, Prosthetic implants, Total hip replacement, Metal, Ceramic, Polyethylene,
Revision hip replacement
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Background
Total hip replacement (THR) is one of the most common
elective procedures performed worldwide. In the USA in
2010, the estimated numbers of hospital discharges after
THR procedures were 332,000 [1]. In England, Wales, and
Northern Ireland, 98,279 THR operations were performed
in 2014 [2, 3]. The main indications for elective hip
replacement are pain and functional limitations due to
osteoarthritis [4, 5].
In a primary THR, both the acetabulum and the fem-
oral head are replaced: a metal stem is inserted into the
femur with a modular head, made of metal or ceramic,
and articulates with an artificial cup, the acetabular
component. The acetabular component can either be a
monobloc polyethylene component or a modular com-
ponent consisting of a metal outer shell with an inner
liner made of polyethylene, ceramic, or metal. The
femoral stem and the acetabular component are attached
to host bone with or without cement. In a resurfacing
hip replacement, the femoral head is not removed but is
instead trimmed and capped with a smooth metal
covering. The acetabulum is removed and replaced with
an all-metal monobloc acetabular component.
Implants have four main combinations of head and
acetabular materials: metal-on-polyethylene, metal-on-
metal, ceramic-on-ceramic, and ceramic-on-polyethylene.
Ceramic-on-metal combinations also exist but are ex-
tremely rare. Head sizes vary, ranging from 22.225 mm to
50 mm in diameter. Heads are broadly categorised as
“large” if 36 mm in diameter and over and “small” if less
than 36 mm. As both the femoral and acetabular compo-
nents can be implanted with or without cement, the pos-
sible combinations of fixation are cemented (when both
components are cemented), uncemented (when neither
prosthesis is cemented), hybrid (when the femoral com-
ponent but not the acetabular component is cemented) or
reverse hybrid (when the acetabular but not femoral com-
ponent is cemented).
Recent NICE guidance advises the use of prostheses
that have rates (or projected rates) of revision of 5 % or
less at 10 years [6]. For hip surgeons, implant choice is
driven mainly by survival: the implant should outlast the
remaining lifetime of the patient and should be easy to
revise if it fails. When an implant fails, for example due
to infection, dislocation or loosening, patients may en-
dure severe pain and require a revision hip replacement.
In England, Wales, and Northern Ireland, in 2014, 10 %
(9516) of the THR procedures performed were revision
hip replacements [2, 3].
Why it is important to do this review
There has been much debate about materials used for
prosthetic implants in THR. Metal-on-polyethylene
cemented implants were developed in the 1950s. They
have a long track record of use and are still the cheapest
and most prevalent type of hip implant. However, the
polyethylene component wears with increased physical
activity and load [7, 8]. This results in loosening and
bone loss over time, which is of particular significance in
younger more active patients. Alternative materials, head
sizes, and fixation techniques have subsequently been
developed to improve long-term survival and patient
outcomes. Metal-on-metal and ceramic-on-ceramic bea-
rings have lower wear rates and larger heads should be
more difficult to dislocate but may have higher volumet-
ric wear.
In a study of observational data, metal-on-metal im-
plants failed more often than traditional metal-on-plastic
implants [9, 10], which caused much concern to patients
and clinicians [11]. Some studies (mainly cohort studies
and a few small trials) suggest that newer ceramic-on-
ceramic prostheses perform better in younger and active
patients [12], and their use is increasing in the UK [13].
However, they can cost up to four times more than
metal-on-polyethylene implants. More recently, a sys-
tematic review on implants for total and resurfacing hip
replacement was published [14]. However, this review
was truncated to recent and large studies, focused on
functional outcomes, and did not inform the subsequent
cost-effectiveness model [15].
We aim to conduct a systematic review of all pub-
lished randomised controlled trials (RCTs) comparing
outcomes of bearing surface combinations, head sizes,
and fixation techniques used in THR. We will use net-
work meta-analyses to combine direct and indirect evi-
dence from the RCTs to obtain relative treatment effect
estimates of revision rates for bearing surface, head size,
and fixation technique permutations available in the
literature. Data collected in this systematic review and
meta-analyses will inform a future cost-effectiveness de-
cision analytic model to compare the cost-effectiveness
of all different implant combinations in current clinical
practice.
Methods/design
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs).
Types of participants
Patients aged 18 years and older receiving primary THR.
Populations in trials should have a diagnosis of osteo-
arthritis in a majority of patients.
Types of interventions and comparators
We will include comparisons among all the THR im-
plant combinations listed in Table 1. Although this lists
up to 33 different implant combinations, some are rare
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(e.g. reverse hybrids) and not all implant combinations
will be reported in the literature. Eligible studies will
make comparisons of any combination of different
bearing material combinations, different head sizes (large
[≥36 mm] or small [<36 mm]), different fixation tech-
niques (uncemented, cemented, hybrids, or reverse hy-
brids), or comparisons of any combination of these three
aspects with resurfacing.
Although some materials (e.g. metal-on-metal implants)
are now recommended less often in clinical practice, and
resurfacing hip replacements are not THR surgeries, they
will be included in this review when compared to THR in
an RCT, as they may provide important common com-
parator interventions in the network of studies, facilitating
relevant indirect comparisons.
Types of outcomes
Implants fail for a myriad of reasons (e.g. dislocation, pain,
loosening, infection) [3], and decision to revise a failed im-
plant is always multifactorial. Without one clear reason
for implant failure, revision rate and timing of revision is a
key proxy measure for effectiveness of implants. Studies
which do not report revision, time to revision, or person-
years at risk will not be included in the meta-analysis of
primary outcome but will be included in the narrative
review and analysis of secondary outcomes.
Primary outcomes
The primary outcome will be the revision rate for the
primary THR surgery at any time after surgery.
Secondary outcomes
Secondary outcome data collection will include the
following:
 Number of revisions at all follow-up times reported,
and Kaplan-Meier curves, to facilitate fitting survival
models;
 Mortality and time to death;
 Complications (e.g. infections);
 Generic quality of life scores, such as the EuroQol
questionnaire and other preference based utility
scores [16];
 Other patient-reported scores. These include, the
Oxford Hip Score [17] and Western Ontario and
McMaster Universities Arthritis Index [18];
 Surgeon completed scores such as the Harris Hip
Score [19];
Exclusion criteria
We will exclude studies on revision THR; emergency sur-
gery, studies where the majority of patients (n > 50 %) are
receiving THR for less common causes (e.g. osteonecrosis);
and comparison of single components (e.g. stems, cups,
shells) when they do not produce a different bearing
surface combination on their own. We will also exclude
studies that only report outcomes gained from revised im-
plants or autopsies, and laboratory and animal studies.
Search methods for identification of studies
Our literature search will target studies comparing
different bearing surface materials and different head
sizes. The literature on fixation technique is extensive,
and a systematic review was published in 2013 [20]. We
will extract data from the RCTs included in their review
and update their search to identify more recent RCTs.
Electronic searches
The following electronic databases will be searched,
without language restrictions:
 MEDLINE;
 Embase;
 Cochrane Library (including reviews, trials,
technology assessments, economic evaluations, and
Cochrane groups);
 Trials databases— clinicaltrials.gov, World Health
Organization International Clinical Trials Registry
Platform, EU Clinical Trials Register.
The search strategies are based on those commonly used
in Cochrane reviews, developed by the authors in collabor-
ation with three orthopaedic surgeons and an information
specialist. Search strategies are customised for each data-
base. A generic search strategy is shown in Table 2.
Table 1 All hip prosthetic implant combinations to be
compared, if available
Materials Head size Fixation technique
Ceramic-on-ceramic Large ≥36 mm With cement
Small <36 mm Without cement
Hybrid
Reverse hybrid
Metal-on-metal Large ≥36 mm With cement
Small <36 mm Without cement
Hybrid
Reverse hybrid
Metal-on-polyethylene Large ≥36 mm With cement
Small <36 mm Without cement
Hybrid cement
Reverse hybrid
Ceramic-on-polyethylene Large ≥36 mm With cement
Small <36 mm Without cement
Hybrid cement
Reverse hybrid
Resurfacings
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Searching other resources
We will inspect reference lists of published papers and
citations of key articles using Web of Science citation
tracking, to identify further studies. Websites of ortho-
paedic conferences since January 2012 will be examined
to identify studies which have been presented but not
yet fully published. Potentially eligible references identi-
fied will be retrieved.
Data collection
Selection of studies
All titles and abstracts will be screened independently by
two reviewers. Both reviewers will independently decide on
whether to obtain the full papers for further assessment or
exclude the study. Full text papers will be obtained for all
potentially relevant studies and independently examined by
Table 2 Search strategy for Embase
1. hip prosthesis.mp. or exp hip prosthesis/
2. hip prosthesis/ or total hip prosthesis/ or exp hip arthroplasty/
or total hip.mp.
3. exp hip surgery/ or hip/
4. hip replacement.mp
5. (THR or THA).tw.
6. (hip adj3 (arthropl$ or pros$ or surg$ or replac$)).ti,ab.
7. Hip joint.mp
8. Or/1-7
9. randomised controlled trial/
10. “randomised controlled trial (topic)”/
11. controlled clinical trial/
12. randomi#ed.ab.
13. randomly.ab,ti
14. random.ti
15. random*.tw
16. “clinical trial (topic)”/
17. trial.ab,ti
18. meta-analys:.mp
19. Systematic review.tw.
20. Search:.tw
21. Review.pt.
22. Or/9-21
23. ceramic.mp. or Ceramics/
24. Zirconium.mp. or Zirconium/
25. alumina.mp. or Aluminum Oxide/
26. oxinium.tw
27. cerasul.tw.
28. CoM.tw.
29. CoC.tw.
30. CoP.tw.
31. polyethylene.mp. or Polyethylene/
32. plastic.mp. or Plastic/
33. UHMWPE.mp. or ultra high molecular weight polyethylene/
34. XLPE.mp.
35. X3.mp.
36. Metal on metal joint prosthesis/ or metal.mp. or metal/
or metal implant/
37. MoM.mp.
38. cobalt.mp. or Cobalt/
39. chrome.mp or chromium/
40. metallic.mp.
41. metasul.tw.
42. MoP.mp.
43. hard on hard.mp.
44. Hard-on-soft.mp.
Table 2 Search strategy for Embase (Continued)
45. alloy.mp. or alloy/
46. bearing.mp
47. (resurf$ or re-surf$).mp. [mp = ti, ab, rw, sh]
48. 22 mm.tw or 22 mm.tw
49. 24 mm.tw or 24 mm.tw
50. 26 mm.tw or 26 mm.tw
51. 28 mm.tw or 28 mm.tw
52. 30 mm.tw or 30 mm.tw
53. 32 mm.tw or 32 mm.tw
54. 34 mm.tw or 34 mm.tw
55. 36 mm.tw or 36 mm.tw
56. 38 mm.tw or 38 mm.tw
57. 40 mm.tw or 40 mm.tw
58. 42 mm.tw or 42 mm.tw
59. 44 mm.tw or 44 mm.tw
60. 46 mm.tw or 46 mm.tw
61. 48 mm.tw or 48 mm.tw
62. 50 mm.tw or 50 mm.tw
63. 52 mm.tw or 52 mm.tw
64. 54 mm.tw or 54 mm.tw
65. 56 mm.tw or 56 mm.tw
66. 58 mm.tw or 58 mm.tw
67. 60 mm.tw or 60 mm.tw
68. (BHR or Conserve Plus or Durom or Cormet or ASR or ReCap).ti,ab
69. head size.mp.
70. femoral adj2 size
71. large adj2 head
72. femoral adj2 head
73. or/23-72
74. 8 and 22 and 73
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both reviewers to assess final inclusion or exclusion. At
both stages, disagreements will be resolved by consensus,
with input from other team members if necessary.
Where possible, studies will be identified by trial regis-
try numbers to flag multiple publications from the same
RCT. Where trial registry numbers are not available, we
will identify multiple publications from RCTs by examin-
ing information on authors, region or centre, participant
numbers, calendar years of recruitment, interventions
compared, study title, or by contacting the authors.
Data from multiple publications on the same RCT will
be combined into a single data entry.
Data extraction and management
Data extraction will be carried out by one reviewer and
checked by the other for accuracy. We will extract data
on the following:
 Participant details, such as eligibility criteria,
proportion of patients with osteoarthritis (if available),
number of participants, age, and gender;
 Details on the intervention, such as components,
materials, fixation technique, head size, and
manufacturer;
 Number of revision surgeries and outcomes defined
above;
 Trial details, such as country of origin, authors,
study year, and years of patient recruitment;
 Surgical details, such as surgical approach;
 Resource use data (if available), such as operation
time, length of hospital stay, and follow-up visits.
We will collect number of events (e.g. number of
revisions) and dichotomous outcomes and means, me-
dians, and measures of variance (i.e. standard deviations,
confidence intervals, interquartile ranges, and ranges)
for continuous outcomes.
Data will be entered into an Access Database designed
for this study.
Assessment of risk of bias in included studies
We will use the Cochrane Collaboration risk of bias tool
to assess selection, performance, detection, attrition, and
reporting bias [21]. An attempt will be made to detect
selective outcome reporting by comparing registered
protocols to published outcomes. We will report sum-
mary assessments of risk of bias (high, low, or unclear)
for each outcome in each trial.
Measures of treatment effect
Where possible, we will extract data according to the
intervention patients were randomised to, in line with
intention to treat principles. The measure of treatment
effect for revision surgery, the primary outcome, will be
the hazard ratio. For secondary outcomes, such as
patient-reported outcome scales, will use mean differ-
ences or standardised mean differences as measures of
treatment effect, depending on whether the same scale is
used or not.
Unit of analysis issues
The unit of analysis will be the patient hip, with a single
measurement for each outcome from each patient hip.
Patients who have bilateral THR will be analysed as a
single measurement of time to first revision.
Dealing with missing data
We will contact authors for additional information when
necessary. This may include missing data, loss to follow-
up, and unpublished outcomes, as well as study charac-
teristics and issues relating to risk of bias. We will also
contact authors of registered trials that have not pub-
lished their results. A maximum of three attempts will
be made to contact authors, by e-mail initially, and/or
telephone later.
Assessment of reporting biases
If 10 or more studies are included in the pairwise meta-
analyses, we will also produce funnel plots. If asymmetry
is found, we will investigate potential causes. Hetero-
geneity between studies can lead to asymmetry, without
reporting bias present [22]. We will look at the spread of
across studies in the analysis (e.g. size, setting) and study
characteristics (e.g. differences in implants compared, pop-
ulations, baseline characteristics) to determine whether
asymmetry may be due to publication bias or genuine dif-
ferences between studies. Inspection of trial registries will
identify trials with delayed reporting.
This protocol follows the PRISMA-P 2015 guide-
lines [23].
Data synthesis
Descriptive analyses
We will summarise key findings and the report of other
outcomes descriptively.
The validity of the data synthesis will depend on the
assumption that included studies do not differ in im-
portant effect modifiers [24–26]. Clinicians identified
patient age and surgical approach as important effect
modifiers. We will further explore whether other patient
characteristics (e.g. baseline descriptive variables such as
gender, weight) are balanced across trials and the net-
work of studies and seek clinical advice to assess the
plausibility of this assumption. Imbalances in these char-
acteristics may explain potential heterogeneity or incon-
sistencies across trials. If enough data are available, we
will control for effect modifiers using meta-regression.
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For the primary outcome, we will use hazard ratios to
compare revision rates for different interventions. In the
main analysis, we will assume constant hazards with an
adjustment for early revisions (due to causes including
infection or surgical errors) and use the longest available
follow-up period. In a second analysis, we will assume
piecewise constant hazards considering three follow-up
points (an “early stage” of 1 or 2 years after primary
surgery, a “medium stage” possibly 5 years, and a “late
stage” ideally at 10 years), which allows for time-varying
deviations from the proportional hazards assumption.
For both analyses, we will estimate person-years at risk
from the mean follow-up times reported in the studies,
or use median follow-up or fixed follow-up if the former
is not available.
Pairwise meta-analysis
Statistical integration will start with standard meta-
analysis for each pairwise comparison of prosthesis com-
bination and year of outcome reported. We will explore
heterogeneity including risk of bias and other potential
effect modifiers (more information in heterogeneity assess-
ment section). We will report both fixed-effect and
random-effects meta-analysis results and quantify between-
study heterogeneity using the between-study variance (τ2)
and the I2 statistic [27].
Network meta-analysis (NMA)
We will construct a network of studies comparing im-
plant combinations. NMA allows the synthesis of results
from trials of interventions that form a connected net-
work of intervention comparisons, so that direct (head-
to-head) and indirect (through common comparators in
different RCTs) evidence can be statistically combined
[24, 28, 29]. NMA also enables the ranking of treatments
according to the probability that each is the best, second
best, and so on, for a given outcome.
NMA assumes consistency between direct and indirect
evidence for a given contrast [30]. NMA can only be
conducted on evidence networks that are connected.
The primary analysis will be the most disaggregate level
of implant combinations that data allow. In the most
aggregate case, we will compare implants by bearing
surface combination only. For a more refined analysis,
we will expand the network to include implant combina-
tions by head size and fixation technique. This will mean
more implant combinations or “nodes” being compared
in the network. The network will also include studies
that compare primary THR with resurfacing hip replace-
ment to provide further indirect evidence. All analyses
will be performed within a Bayesian framework, evalu-
ated using Monte Carlo Markov chain simulation com-
puted in WinBUGS.
NMA methods have been extended to estimate
treatment effects with multiple follow-up times given as-
sumptions about the underlying time-course of the treat-
ment effects [31, 32]. We will fit survival curves with
hazard ratios that may vary with time (e.g. piecewise
constant). This information will define a distribution of
effects across time and inform the extrapolation of long-
term outcomes from other data sources to inform the
future economic model.
Assessment of statistical inconsistency
The statistical agreement (often called consistency or co-
herence) between the various sources of evidence in the
networks of interventions will be evaluated. In NMA, we
require that the relative effects on an appropriate scale
(log-hazard here) “add-up”, in the sense that the log-
hazard ratio for the comparison of implants A vs C is
the sum of the log-hazard ratio for implants A vs B and
B vs C. We will implement both a local approach for
comparisons involved in a closed loop of evidence (using
node splitting [25, 30]) and a global approach to exam-
ine evidence of inconsistency in the network as a whole.
Results will be presented separately for direct compari-
sons, indirect comparisons, and network meta-analyses.
This statistical assessment of consistency complements
our clinically focussed evaluation of the plausibility of
consistency through the assessment of clinical homo-
geneity of patient characteristics in the included studies.
Subgroup and sensitivity analyses
These will examine the extent to which study character-
istics explain between-study heterogeneity [33]. If data
allow, we will investigate whether revision rates vary
according to key participant and trial characteristics, in-
cluding age and surgical approach, in meta-regression
analyses.
If a majority of studies (>50 %) are assessed as being at
low or unclear risk of bias and these form a connected
network of all evaluated implant combinations, our pri-
mary analysis will include only these RCTs, with the full
network of studies results as secondary analysis. In sen-
sitivity analysis, we will then re-estimate the results also
including studies with potential high risk of bias. We
will perform sensitivity analysis to the model assump-
tions, particularly to the model for the survival curve
and hazard ratio (i.e. assuming increasing hazards, con-
stant hazards, etc.)
Secondary analyses
If data allows for meta-analysis of secondary continuous
outcomes, such as patient-reported outcome scales, we
will use mean differences, or standardised mean differ-
ences, depending on whether the same scale is used or
not, to measure similar outcomes across studies.
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Discussion
There has been much debate about materials used for
prosthetic implants in THR. Different combinations of
prosthetic materials, sizes, and fixation can vary widely
in cost and fail at different rates for different patient
groups. Given the number of THR surgeries performed
yearly, and the increasing use of expensive implants, it is
important to review all available evidence to inform
surgeons, patients, and health care providers of optimal
implant combinations for given patient characteristics.
A recent health technology assessment report reviewed
the clinical effectiveness and cost-effectiveness of hip re-
surfacing and THR [14]. However, the outcomes reported
focused on surgeon and patient function scores, and only
large studies (with sample size larger than 100 patients)
published between the years of 2008 and 2013 were
included. The subsequent economic model included only
five types of commonly used prosthesis, did not take into
consideration head size, and the model parameters were
not populated by the systematic review evidence.
This review will compare the evidence on implant bear-
ing surfaces, head sizes, and fixation techniques that are
used in primary THR. This review will synthesize all direct
and indirect evidence available in the literature to deter-
mine the most effective implant type for a patient group
of given characteristics. Our analyses will be intended to
inform health care decisions in the long term, which may
entail extrapolation of results from studies where only
short-term follow-up periods were considered. The poten-
tial problems of such extrapolations have been highlighted
before in the field of total hip replacement [34], and there-
fore, we will interpret these results cautiously. The results
of this review will be combined with other data sources to
inform a cost-effectiveness model to determine the most
cost-effective implant combination for each patient group.
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